ARTICLES BY THIS AUTHOR
- 9/24/2020
The September issue is now out!
The September issue of <em>Pharmacy Practice + Business </em>is now available to read online. Check it out for updated Drug News, clinical and practice features and more. - 9/23/2020
The before and after of our lives
- 9/23/2020
Key clinical guidelines and statements – June to August, 2020
Most recent updates include resources on cannabis in adolescents, corticosteroids for bronchopulmonary dysplasia in preterm infants, COVID-19, dementia, diabetes-low carbohydrate diets, influenza 2020/21, naloxone, obesity, pulmonary arterial hypertension, syncope, ventricular tachycardia/fibrillation. - 9/23/2020
Women and children first
- 9/23/2020
Residency in the time of the pandemic
As the pandemic wore on, it became increasingly clear that our normal, pre-pandemic lives were bound for the past tense. As a resident in family medicine, I wondered what this might mean for our patient relationships. Would we develop the same rapport, or be able to guide our patients through maintaining health and treating illness as closely and meaningfully as before? - 9/23/2020
Rexall in PPN partnership with Reformulary Group
A preferred pharmacy network (PPN) partnership between Reformulary Group and Rexall offers drug plan sponsors and their members access to exclusive savings on Rexall-branded products. - 9/23/2020
Emgality (galcanezumab) now indicated to reduce cluster headache frequency
CGRP binding antibody is first drug approved by Health Canada to help prevent episodic cluster headaches